feed,title,long_url,short_url
Benzinga,AstraZeneca Revises COVID-19 Vaccine Efficacy To 76% After Controversy,https://benzinga.com/general/biotech/21/03/20332319/astrazeneca-revises-covid-19-vaccine-efficacy-to-76-after-controversy,https://j.mp/3coOWZX
